Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

DFFN Diffusion Pharmaceuticals

Watchlist
5.3820.0000.00%
Trading Session 09/30 11:14 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
0.000
Open
5.400
Turnover
1.16K
Low
0.000
Pre Close
5.382
Volume
213
Market Cap
10.97M
P/E(TTM)
Loss
52wk High
26.175
Shares
2.04M
P/E(Static)
Loss
52wk Low
5.100
Float Cap
10.95M
Bid/Ask %
0.00%
Historical High
2249999775.000
Shs Float
2.03M
Volume Ratio
0.15
Historical Low
5.100
Dividend TTM
--
Div Yield TTM
--
P/B
0.41
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.01%
Amplitude
0.00%
Avg Price
5.460
Lot Size
1
Float Cap
10.95M
Bid/Ask %
0.00%
Historical High
2249999775.000
Shs Float
2.03M
Volume Ratio
0.15
Historical Low
5.100
Dividend TTM
--
P/B
0.41
Dividend LFY
--
Turnover Ratio
0.01%
Amplitude
0.00%
Avg Price
5.460
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body’s ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.
CEO: Cobuzzi Jr., Ph.D., Robert J.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top